Significados de human tumour en inglés

In human tumours, DIAPH3 down-regulation was associated with aggressive or metastatic disease.

In human tumours, a number of different proteases also correlate with metastatic potential.

Recent evidence suggests that Runt-related transcription factors play a role in different human tumours.

The tumour suppressor gene TP53 is the most frequently mutated gene in human tumours.

Most human tumours are heterogeneous, composed of cellular clones with different properties present at variable frequencies.

Expression of class I HLA antigen has been shown to be reduced in a number of human tumours.

Here we capitalize on the availability of multi-platform data on thousands of human tumours to build integrative models of DNA methylation.

While tumour cells migrate through tissues using diverse strategies, the signalling networks controlling such behaviours in human tumours are poorly understood.

The bcl-2 protein is found to be over-expressed in many types of human tumours and is a potent inhibitor of apoptosis.

Preliminary data from Phase I clinical trials indicate that cis CA-4 may also be effective in targeting the vasculature of human tumours.

This suggests that the presence of somatostatin receptors on human tumours does not automatically imply a beneficial effect of somatostatin analogue therapy.

An increasing number of scientific reports have described evidence for a polyomavirus, simian virus 40, in a highly select group of human tumours.

We have used a polyclonal antibody to recombinant human TS to establish a silver-enhanced immunogold staining method to localize TS in human tumours.

Human tumour cell lines with acquired resistance to TS inhibitors owing to increased levels of TS were used to confirm the specificity of immunostaining.

The TP53 mutation patterns induced by these mutagens in the HIMA corresponded to those found in human tumours from patients exposed to these mutagens.

TP53 mutation spectra generated can be compared with those of human tumours recorded in the International Agency for Research on Cancer TP53 mutation database.